Clinical validation of an in-house quantitative real time PCR assay for cytomegalovirus infection using the 1 WHO International Standard in kidney transplant patients
Brazilian Journal of Nephrology, ISSN: 2175-8239, Vol: 43, Issue: 4, Page: 530-538
2021
- 1Citations
- 127Usage
- 22Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Introduction: Cytomegalovirus (CMV) is one of the most common agents of infection in solid organ transplant patients, with significant morbidity and mortality. Objective: This study aimed to establish a threshold for initiation of preemptive treatment. In addition, the study compared the performance of antigenemia with qPCR results. Study design: This was a prospective cohort study conducted in 2017 in a single kidney transplant center in Brazil. Clinical validation was performed by comparing in-house qPCR results, against standard of care at that time (Pp65 CMV Antigenemia). ROC curve analysis was performed to determine the ideal threshold for initiation of preemptive therapy based on the qPCR test results. Results: Two hundred and thirty two samples from 30 patients were tested with both antigenemia and qPCR, from which 163 (70.26%) were concordant (Kappa coefficient: 0.435, p<0.001; Spearman correlation: 0.663). PCR allowed for early diagnoses. The median number of days for the first positive result was 50 (range, 24-105) for antigenemia and 42 (range, 24-74) for qPCR (p<0.001). ROC curve analysis revealed that at a threshold of 3,430 IU/mL (Log 3.54), qPCR had a sensitivity of 97.06% and a specificity of 74.24% (AUC 0.92617 ± 0.0185, p<0.001), in the prediction of 10 cells/10 leukocytes by antigenemia and physician's decision to treat. Conclusions: CMV Pp65 antigenemia and CMV qPCR showed fair agreement and a moderate correlation in this study. The in-house qPCR was revealed to be an accurate method to determine CMV DNAemia in kidney transplant patients, resulting in positive results weeks before antigenemia.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85122772077&origin=inward; http://dx.doi.org/10.1590/2175-8239-jbn-2020-0214; http://www.ncbi.nlm.nih.gov/pubmed/33970997; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400530&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021005040301&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0101-28002021005040301&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021005040301; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0101-28002021005040301; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400530&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0101-28002021000400530&lng=en&tlng=en; http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0101-28002021000400530; http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0101-28002021000400530; https://dx.doi.org/10.1590/2175-8239-jbn-2020-0214; https://www.scielo.br/j/jbn/a/RY7nX5GLxFw9gCJk9DpxGVc/?lang=en
FapUNIFESP (SciELO)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know